Search

everythinglearnresearchcommunity

for

Search:↓

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Birth control pills can help reduce mild to moderate acne in women.

Oral contraceptives may cause hair loss in women.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Young women with PCOS without additional risk factors may have normal heart function.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.